
Azenta, Inc. (NASDAQ:AZTA – Free Report) – Investment analysts at KeyCorp issued their Q1 2027 earnings per share estimates for shares of Azenta in a research report issued on Wednesday, November 11th. KeyCorp analyst P. Knight forecasts that the company will post earnings per share of $0.15 for the quarter. The consensus estimate for Azenta’s current full-year earnings is $0.69 per share. KeyCorp also issued estimates for Azenta’s Q2 2027 earnings at $0.09 EPS, Q3 2027 earnings at $0.19 EPS, Q4 2027 earnings at $0.26 EPS, FY2027 earnings at $0.69 EPS and FY2028 earnings at $0.84 EPS.
Other analysts also recently issued research reports about the stock. Wall Street Zen raised shares of Azenta from a “hold” rating to a “buy” rating in a research report on Saturday. Jefferies Financial Group upped their price objective on shares of Azenta from $44.00 to $52.00 and gave the stock a “buy” rating in a report on Wednesday. Needham & Company LLC boosted their target price on shares of Azenta from $37.00 to $57.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Weiss Ratings upgraded shares of Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 26th. Four investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $47.60.
Azenta Stock Performance
Shares of NASDAQ AZTA traded up $1.79 during midday trading on Friday, hitting $45.65. 1,114,037 shares of the stock traded hands, compared to its average volume of 964,725. The company has a market cap of $2.00 billion, a PE ratio of -12.61 and a beta of 1.47. Azenta has a one year low of $15.93 and a one year high of $50.06. The business has a 50 day moving average price of $36.52 and a two-hundred day moving average price of $28.56.
Azenta (NASDAQ:AZTA – Get Free Report) last announced its quarterly earnings results on Tuesday, November 10th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.17. Azenta had a positive return on equity of 1.41% and a negative net margin of 26.86%. The business had revenue of $167.09 million for the quarter, compared to analyst estimates of $160.16 million.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in the company. Legal & General Group Plc bought a new stake in Azenta in the second quarter worth about $2,453,000. Hsbc Holdings PLC purchased a new position in Azenta in the second quarter valued at about $1,108,000. Jupiter Topco LLC bought a new position in shares of Azenta during the 2nd quarter valued at approximately $435,000. Meros Investment Management LP bought a new position in shares of Azenta during the 2nd quarter valued at approximately $5,625,399. Finally, Man Group plc bought a new position in shares of Azenta during the 2nd quarter valued at approximately $9,402,000. 99.08% of the stock is owned by institutional investors.
Azenta News Summary
Investors following AZTA have been watching these news items:
- Positive Sentiment: Better-than-expected quarterly results helped fuel buying: Azenta reported earnings of $0.28 per share versus analysts’ $0.11 estimate, and revenue of $167.1 million, above the $160.2 million consensus. Shares subsequently reached a 52-week high. Article: Azenta Reaches New 52-Week High Following Better-Than-Expected Earnings
- Positive Sentiment: Needham raised its price target to $57 from $37 and maintained a Buy rating, signaling greater optimism about potential upside. Article: Needham Raises Azenta Price Target
- Neutral Sentiment: After the sharp post-earnings advance, some investors took profits, contributing to a pullback; this may reflect near-term trading rather than a change in the company’s fundamentals. Article: Azenta Dips as Investors Book Profits
About Azenta
Azenta, Inc. provides products and services for life sciences research and the management of biological samples. Its offerings include automated sample storage systems, laboratory automation equipment, consumables, and software used to track and manage samples. The company also provides genomic services through GENEWIZ, including sequencing and other genetic analysis services for researchers and organizations in the life sciences and pharmaceutical industries. Azenta was formed in 2021 when Brooks Automation separated its life sciences business and adopted the Azenta name.
Read More
- Five stocks we like better than Azenta
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
- 3 GARP Plays That Could Offer a Better Balance as Markets Turn Volatile
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.
